SONM DNA X, Inc.

Price Chart

Executive Summary

DNA X, Inc. (SONM) disclosed a Nasdaq delisting determination due to a stockholders' deficit of $983,000, violating the $2.5M minimum equity requirement. Concurrently, the company raised $1.8M in new cash via a secured convertible note (total principal $3.05M) from its existing controlling shareholder, who also agreed to terminate a put option that could have forced a reverse acquisition. The delisting risk dominates the filing, as the capital raise is a distressed lifeline from a related party, not an arm's-length vote of confidence.

Key Financial Metrics

Actionable Insight

Key Facts

• Nasdaq delisting determination received May 22, 2026; trading suspension scheduled for June 2, 2026 unless hearing is requested by May 29, 2026.
• Company reported stockholders' deficit of $983,000 as of March 31, 2026, violating Nasdaq's $2.5M minimum equity requirement.
• Company issued a $3,052,787.68 secured convertible promissory note to DNA Holdings Venture, Inc., its controlling shareholder, for $1.8M cash plus conversion of a prior $1.2M bridge note.
• The note matures December 31, 2026, bears 10% interest (20% upon default), and is convertible at $6.00/share subject to stockholder approval.
• The note is secured by a first-priority lien on the membership interests of the company's wholly owned subsidiary, DNA X, LLC.
• The put option in the prior Membership Interest Purchase Agreement was terminated as part of the transaction.
• Market cap is approximately $6M; the $1.8M cash infusion represents ~30% of market cap.

Financial Impact

The $1.8M cash infusion provides near-term liquidity but is dwarfed by the existential risk of Nasdaq delisting. The company's $983K stockholders' deficit indicates negative equity.

Risk Factors

• Nasdaq delisting would severely reduce liquidity and institutional ownership, likely causing a material price decline.
• The company has negative stockholders' equity and may require additional dilutive financing.
• The secured note gives the holder a priority claim on the subsidiary's assets, potentially impairing other stakeholders.
• The company may need to execute a reverse stock split to regain compliance, which often depresses stock price.
• The note's 20% default interest rate and aggressive conversion terms (80% of market price upon default) create a strong incentive for the holder to trigger default if the stock declines.

Market Snapshot

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

US Market Status